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H I G H L I G H T S
• In this large population-based study, calcification in the vertebrobasilar arteries was prevalent in 21% of the elderly.• Calcification in the vertebrobasilar arteries was weak to moderately correlated with calcification in other arteries.• Traditional cardiovascular risk factors were associated with vertebrobasilar artery calcification.• Our findings suggest a different pathophysiology of arteriosclerosis in the posterior- compared to anterior circulation.
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A B S T R A C T
Background and aims: Arteriosclerosis in the vertebrobasilar arteries may play an important role in the etiology
of posterior circulation strokes, but little is known on its prevalence, its correlation with arteriosclerosis in other
major arteries, and its risk factors. Hence, we investigated these aspects of vertebrobasilar artery calcification
(VBAC) as marker of vertebrobasilar arteriosclerosis.
Methods: To quantify VBAC, 2483 participants (mean age: 69.2 years, 52% female) from the Rotterdam Study
underwent non-enhanced computed tomography. We determined the presence and volume of VBAC. Next, using
Spearman's rank correlation, we examined the correlation between the volume of VBAC and the volume of
coronary artery calcification (CAC), aortic arch calcification (AAC), and both extracranial- (ECAC), and in-
tracranial carotid artery calcification (ICAC). Finally, we investigated associations of cardiovascular risk factors
with the presence and volume of VBAC using logistic and linear regression models.
Results: The overall prevalence of VBAC was 21.0% (median volume: 7.3mm3 [IQR: 2.0–25.6]). Correlations
between VBAC and CAC, AAC, ECAC, and ICAC were weak to moderate (men: 0.33, 0.28, 0.30, 0.36; women:
0.26, 0.24, 0.24, 0.35, respectively). Hypertension, diabetes, and current smoking were associated with the
presence of VBAC in both sexes (men: OR 1.67 [95%-CI, 1.14–2.46], 1.60 [95%-CI, 1.10–2.34], 1.48 [95%-CI,
1.02–2.14]; women: OR 1.51 [95%-CI, 1.01–2.26], 1.56 [95%-CI, 1.02–2.39], 1.53 [95%CI, 1.00–2.33], re-
spectively). In men, obesity was also associated with VBAC (1.42 [95%-CI, 1.00–2.02]).
Conclusions: VBAC occurs in over 20% of elderly community dwelling persons. Cardiovascular risk factors are
associated with VBAC with similar patterns for men and women.
1. Introduction
Within the multifactorial etiological framework of ischemic stroke,
intracranial arteriosclerosis is increasingly established as one of the
most important risk factors worldwide [1,2]. Yet, important knowledge
gaps pertaining to its prevalence and etiology remain. First, the vast
majority of research has focused on the occurrence and risk factors of
arteriosclerosis in the intracranial internal carotid artery as proxy of the
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anterior cerebral circulation [3,4]. Conversely, complementary data on
arteriosclerosis in the posterior circulation, for which the vertebroba-
silar arteries may be regarded as proxy, remain scarce [5]. However, up
to a quarter of all ischemic strokes originate from the posterior circu-
lation and may lead to a wide spectrum of symptoms ranging from
vertigo or ataxia to severe locked-in syndromes [6,7]. Second, although
arteriosclerosis occurs systemically across the arterial vasculature, its
burden may vary considerably across arteries, with correlations ranging
from 0.3 to only 0.6 [8–10]. Increasing evidence shows that this var-
iation in arteriosclerotic burden across different arteries may be due to
location-specific discrepancies in susceptibility to cardiovascular risk
factors [10–13]. Additionally, differences in arteriosclerotic vulner-
ability to cardiovascular risk factors between men and women have
been demonstrated [14]. Hence, disentangling the sex-specific asso-
ciations of cardiovascular risk factors with arteriosclerosis in the ver-
tebrobasilar arteries could aid the development of sex-specific pre-
ventive strategies for the occurrence of stroke.
Against this background, we investigated the sex-specific prevalence
and distribution of vertebrobasilar calcification as a proxy for verteb-
robasilar arteriosclerosis, its correlation with arteriosclerosis in other
major arteries, and its risk factors in a large community-dwelling po-
pulation. These novel insights will substantially advance our knowledge
on the magnitude of intracranial arteriosclerosis at large and may
eventually contribute to recommendations for cerebrovascular risk re-
duction [15,16].
2. Materials and methods
2.1. Study population
This study was embedded within the Rotterdam Study, a popula-
tion-based cohort ongoing since 1990 in the Ommoord district in
Rotterdam, comprising over 15,000 participants. Each participant was
examined at study entry and at regular follow-up examinations that
were carried out every three to five years [17]. Between 2003 and
2006, participants that came to the research centre for a study round
were invited to undergo a non-contrast multidetector computed tomo-
graphy (MDCT) scan to visualize arterial calcification in multiple vessel
beds. A total of 2524 participants (response rate: 78%) were scanned.
Due to image artifacts, vertebrobasilar artery calcification (VBAC) was
not gradable in 41 participants, leaving a total of 2483 subjects for the
main analyses. The Rotterdam Study has been approved by the Medical
Ethics Committee of the Erasmus MC (registration number MEC
02.1015) and by the Dutch Ministry of Health, Welfare and Sport
(Population Screening Act WBO, license number 1071272-159521-PG).
The Rotterdam Study has been entered into the Netherlands National
Trial Register (NTR; www.trialregister.nl) and into the WHO Interna-
tional Clinical Trials Registry Platform (ICTRP; www.who.int/ictrp/
network/primary/en/) under shared catalogue number NTR6831. All
participants provided written informed consent to participate in the
study and to have their information obtained from treating physicians.
2.2. Assessment of vertebrobasilar calcification
We used a 16-slice (n= 781) or 64-slice (n= 1702) multidetector
CT scanner (Somatom Sensation, Siemens, Forchheim, Germany) to
visualize VBAC. We assessed VBAC using a scan that ranged from the
aortic root to the circle of Willis (1 cm above the sella turcica) [3,13].
We quantified calcification in the intracranial vertebral arteries from
the level at which the vertebral arteries entered the dura to the level of
merging into the basilar artery. Calcification in the basilar artery was
assessed from the merge of the vertebral arteries to the top of the basilar
artery. Detailed information on the scan protocol has been described in
detail elsewhere [13].
Calcification was scored semi-automatically by drawing regions of
interest (ROI) around calcification in consecutive slices in the course of
the intracranial vertebral arteries and the basilar artery (Fig. 1). In the
ROI, the number of pixels above 130 Hounsfield units (HU) was cal-
culated [3,13,18] and multiplied by pixel-size and the increment to
determine the calcification volume in cubic millimeters, mm3. The
intra- and inter-rater reliability on a random set of 50 scans were ex-
cellent (intra-rater Intraclass-Correlation Coefficient (ICC): 1.000 (95%-
CI: 1.000–1.000; p < 0.001) | inter-rater ICC: 0.997 (95%-CI,
0.995–0.998; p < 0.001).
2.3. Assessment of cardiovascular risk factors and calcification in other
vessel beds
Cardiovascular risk factors were assessed by means of interview,
clinical examination, and blood sampling. Using the interview, we ob-
tained information on smoking habits, and the use of lipid lowering- or
blood pressure lowering medication. Smoking was categorized as ‘cur-
rent smoker’, ‘past smoker’, and ‘never smoker’ [13,19]. We measured
weight and height and calculated body mass index (BMI) [weight/
Fig. 1. Example of different calcification burden within the vertebrobasilar arteries.
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height2 (kg/m2)]. Accordingly, obesity was defined as a BMI of 30 kg/
m2 or higher. Blood pressure was measured twice at the right arm in
sitting position, and the average of two measurements was used. Hy-
pertension was defined as a systolic blood pressure ≥140mmHg and/
or a diastolic blood pressure ≥100mmHg and/or the use of blood
pressure lowering medication [20].
Serum total cholesterol and high-density lipoprotein (HDL) choles-
terol were assessed using an automatic enzymatic procedure (Hitachi
911, Roche CHOD PAP). Hypercholesterolemia was defined as a serum
total cholesterol of ≥6.2mmoL/L [21] and/or the use of lipid lowering
medication. We defined low HDL-cholesterol as HDL<1.0mmoL/L
[21]. Diabetes was defined as fasting plasma glucose ≥7.0mmoL/L
[22] and/or the use of anti-diabetic medication. Information on history
of myocardial infarction (MI), stroke, percutaneous transluminal cor-
onary angioplasty (PCI), and coronary artery bypass graft (CABG) was
collected at baseline and during follow-up visits as described earlier
[23–25]. We defined history of cardiovascular disease (CVD) as history
of MI, stroke, PCI, or CABG. Finally, using the CT-scans we obtained
information on the volume of coronary artery calcification (CAC),
aortic arch calcification (AAC), extracranial carotid artery calcification
(ECAC), and intracranial carotid artery calcification (ICAC). Detailed
description of the methods used for quantification of calcification in
these vascular territories are provided elsewhere [13,26,27].
2.4. Statistical analysis
Descriptive characteristics of the study population were calculated
as means with standard deviations or absolute values with percentages.
Differences in population characteristics according to sex were esti-
mated using chi-square tests for categorical variables and t-tests for
continuous variables. We calculated the overall sex-specific prevalence
of VBAC and examined the prevalence and median volumes of VBAC
based on 10 year age strata [3,4]. Additionally, we calculated sex-
specific prevalences including 95%-confidence intervals (95%-CI) and
median calcification volumes for the left vertebral artery, right ver-
tebral artery, and basilar artery.
Next, we examined the correlation between the volume of VBAC
and the volume of CAC, AAC, ECAC, and ICAC using Spearman's rank
correlation. A nonparametric bootstrap procedure with 1000 replica-
tions was performed to obtain interval estimates of Spearman's Rho. In
order to provide insight into the physiological distribution of calcifi-
cation in the abovementioned vessel beds, we calculated all possible
combinations of affected vessels within persons [28]. For this, and for
the correlation analysis, we used examinations of participants with
complete information on calcification in all vascular beds (N=2,384,
men: 1130 | women: 1254).
Finally, we investigated the association of cardiovascular risk fac-
tors with the presence and volume of VBAC using the following
strategy. First, using logistic regression models, we assessed the asso-
ciation of hypertension, diabetes mellitus, hypercholesterolemia, low
HDL cholesterol, current smoking, and history of CVD with the presence
of VBAC. Second, considering the skewed distribution of VBAC, we
performed a natural log-transformation and added 1mm3 to each non-
transformed volume to deal with calcium scores of 0 (Ln [calcification
volume+1 mm3]). Subsequently, we used linear regression models to
examine the association between the abovementioned risk factors and
volume of VBAC. Model 1 was adjusted for age, cohort, and scanner,
model 2 additionally included all cardiovascular risk factors. All ana-
lyses were stratified by sex. For missing data on cardiovascular risk
factors, we used multiple imputation by chained equation [29] (n=5
imputations) along with age, sex, calcification volumes and cardiovas-
cular risk factors. None of the variables contained more than 6% of
missing data. Statistical analyses were performed with IBM SPSS Sta-
tistics 24.0 (IBM, Chicago, IL, www.spss.com) and R statistical software
(R-project, Institute for Statistics and Mathematics, R Core Team
(2013), Vienna, Austria, version 3.4.4).
3. Results
3.1. Study population
Table 1 shows the characteristics of the study population. Our study
population comprised more women than men (52% versus 48%, re-
spectively), and the mean age (± sd) was 69.2 (± 6.8) years. BMI and
cholesterol levels were higher in women than men. Men had a slightly
higher diastolic blood pressure and serum glucose. The use of blood
pressure and lipid lowering medication was more frequent in men than
women.
3.2. Prevalence and distribution of VBAC
Table 2 shows the sex-specific prevalence and median volumes of
vertebrobasilar calcification. The overall prevalence of VBAC was
21.0%. We found a higher prevalence and larger VBAC volume in men
than women, 23.7% (median volume: 10.4 mm3 [interquartile range
(IQR): 2.7–28.9]) vs. 18.5% (median volume: 5.4mm3 [IQR: 1.5–17.9],
respectively). Calcification was more prevalent in the left vertebral
artery (men: 18.3%, women: 13.8%), followed by calcification of the
right vertebral artery (men: 13.8%, women: 11.2%). Calcification of the
basilar artery was present in only 1.5% of the participants (men: 1.9%,
Table 1
Descriptive characteristics of the study population.
Total, N= 2483 Men, N=1194 Women, N=1289 p-valuea
Age (years) 69.2 ± 6.8 69.3 ± 6.7 69.1 ± 6.9 0.485
Body mass index (kg/m2) 27.7 ± 4.0 27.4 ± 3.4 27.9 ± 4.5 0.005
Obesity 603 (24.3) 253 (21.2) 349 (27.1) 0.001
Systolic blood pressure (mmHg) 146.6 ± 20.3 145.8 ± 19.8 147.4 ± 20.7 0.057
Diastolic blood pressure (mmHg) 80.0 ± 10.9 81.0 ± 10.9 79.1 ± 10.7 <0.001
Hypertension 1825 (73.5) 873 (73.1) 952 (73.9) 0.787
Serum total cholesterol (mmol/l) 5.7 ± 1.0 5.4 ± 1.0 5.9 ± 1.0 <0.001
Serum HDL cholesterol (mmol/l) 1.4 ± 0.4 1.3 ± 0.3 1.6 ± 0.4 <0.001
Hypercholesterolemia 1222 (49.2) 502 (42.1) 720 (55.9) <0.001
HDL <1.0mmoL/l 284 (11.4) 208 (17.4) 75 (5.8) < 0.001
Serum glucose (mmol/l) 5.7 ± 1.3 5.8 ± 1.3 5.7 ± 1.3 0.008
Diabetes mellitus 332 (13.4) 170 (14.2) 161 (12.5) 0.115
Current smoking 392 (15.7) 213 (17.8) 179 (13.9) 0.010
Use of lipid lowering medication 619 (24.9) 303 (25.4) 315 (24.4) 0.497
Use of blood pressure lowering medication 1013 (40.8) 502 (42.0) 512 (39.7) 0.210
History of cardiovascular disease 310 (12.5) 212 (17.8) 98 (7.6) < 0.001
Values are in means ± standard deviations for continuous variables, absolute numbers and percentages for categorical variables.
a p-value of characteristic differences between men and women estimated using t-test for continuous variables, and Chi-square test for categorical variables.
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women: 1.2%). In 0.8% and 0.5% of men and women, respectively,
calcification was present in all three vertebrobasilar arteries (left ver-
tebral artery, right vertebral artery and basilar artery), whereas 7.7% of
the participants (men: 8.9%, women: 6.7%) had calcification in two
vessels and the remaining (men: 14%, women: 11.3%) had single vessel
calcification (Supplementary Fig. I). Table 3 shows an increasing VBAC
prevalence with age, with a higher prevalence and larger volumes in
men than women.
3.3. Calcification in other vessel beds
We found a weak correlation between the volume of VBAC and the
volume CAC, AAC, ECAC, and ICAC. Spearman's correlation coefficients
in men were: 0.33 (95%-CI, 0.27–0.37), 0.28 (95%-CI, 0.23–0.33), 0.30
(95%-CI, 0.24–0.35), 0.36 (95%-CI, 0.31–0.41); in women: 0.26 (95%-
CI, 0.20–0.33), 0.24 (95%-CI, 0.19–0.29), 0.24 (95%-CI, 0.20–0.27),
0.35 (95%-CI, 0.30–0.40).
Considering the distribution of the prevalence of calcification in
different vessel beds, the most common combination was having CAC,
AAC, ECAC, and ICAC in both men and women (N=520, 46%;
N=429, 34% respectively). In men, the second most common com-
bination was having calcification in all vessels (N=217, 19%),
whereas in women the second most common combination of affected
vessels was the aortic arch, coronary, and intracranial carotid arteries.
(N= 155, 12%). Few participants had calcification in only one vessel
bed (Supplementary Fig. II).
3.4. Cardiovascular risk factors for VBAC
Fig. 2 shows the multivariable adjusted associations between car-
diovascular risk factors and the presence of VBAC according to sex. Age,
hypertension, diabetes, and current smoking were associated with the
presence of VBAC in both sexes (odds ratio (OR) for the presence versus
absence of VBAC in men: 1.07 [95%-CI, 1.04–1.09], 1.67 [95%-CI,
1.14–2.46], 1.60 [95%-CI: 1.10–2.34], 1.48 [95%-CI: 1.02–2.14]); in
women: 1.08 [95%-CI, 1.05–1.10], 1.51 [95%-CI, 1.01–2.26), 1.56
[95%CI, 1.02–2.39], 1.53 [95%-CI: 1.00–2.33]). In men, obesity was
also associated with the presence of VBAC (OR: 1.42 [95%-CI,
1.00–2.02]), whereas we found no association between obesity and
VBAC in women. Similar results were found for the continuous analyses
addressing differences in the natural-log-transformed VBAC volumes for
each cardiovascular risk factor (Supplementary Table I).
4. Discussion
In this large population-based study of middle-aged and elderly
participants, we found that the overall prevalence of VBAC was over
20%. In men, VBAC was more prevalent and more severe than in
women. We found weak correlations between the volume of VBAC and
the volume of calcification in four other major vessels. Hypertension,
diabetes, and current smoking were the most prominent risk factors for
the presence and amount of VBAC in both sexes. Moreover, obesity was
associated with VBAC among men.
In our study, the prevalence of VBAC was 21%. Other studies show a
varying VBAC prevalence up to 56% [30–34]. However, contrary to our
population-based study, prior studies were performed among selected
samples of referred patients or ischemic stroke patients, which explains
the large discrepancies with our results as such populations a priori
have a considerably higher chance of arteriosclerosis. The prevalence of
calcification in other vascular territories has been reported within po-
pulation-based settings. For example, within the Rotterdam Study, the
prevalence of ICAC and CAC is approximately 82% and 85%, respec-
tively [3,8]. To our knowledge, our study is the first to show the pre-
valence and risk factors for VBAC in a non-selected population.
Considering the vertebral and basilar arteries separately, we ob-
served a significantly higher prevalence of calcification for the left
vertebral artery (16.0%) compared with the right vertebral artery
(12.4%), whereas the basilar artery was less affected (1.5%), which is
similar to two previously reported studies investigating the distribution
of VBAC among ischemic stroke patients [30,32]. On the contrary, an
autopsy study from France among fatal stroke patients found that
32.7% had some degree of plaque in the basilar arteries, ranging from
non-stenotic to fully occluding [31]. However, this might again be at-
tributed to the disease staging, and to different techniques used to
identify arteriosclerotic disease.
In accordance with previous studies focusing on different vascular
territories [8,10], we found a weak correlation between the volume of
VBAC and volumes of CAC, AAC, ECAC, and ICAC in both sexes, which
further underlines the existence of location-specific differences in the
development of arteriosclerosis. Although the origin of these vessel-
specific differences in susceptibility to arteriosclerosis requires further
investigation, important explanations may be found in vessel-specific
Table 2
Prevalence and volume of intracranial vertebrobasilar artery calcification.
Total, N= 2483 Men, N=1194 Women, N=1289
Prevalence (95%-CI) Calcification volume
(IQR)
Prevalence (95%-CI) Calcification volume
(IQR)
Prevalence (95%-CI) Calcification volume
(IQR)
Vertebrobasilar arteries 21.0 (19.4–22.6) 7.3 (2.0–25.6) 23.7 (21.3–26.1) 10.4 (2.7–28.9) 18.5 (16.3–20.6) 5.4 (1.5–17.9)
Left vertebral artery 16.0 (14.6–17.4) 5.4 (1.3–18.2) 18.3 (16.1–20.5) 8.0 (1.9–24.2) 13.8 (11.9–15.7) 2.9 (0.9–12.1)
Right vertebral artery 12.4 (11.2–13.7) 6.4 (2.2–18.5) 13.8 (11.9–15.8) 7.0 (2.3–23.4) 11.2 (9.5–12.9) 5.9 (1.7–16.9)
Basilar artery 1.5 (1.1–2.0) 3.1 (0.6–9.7) 1.9 (1.2–2.7) 4.0 (1.4–11.7) 1.2 (0.6–1.8) 1.0 (0.5–4.7)
Values represent prevalences in percentages (95%-confidence intervals), and median calcification volumes in mm3 (interquartile range).
Table 3
Prevalence and volume of intracranial vertebrobasilar artery calcification per age category.
Men, N=1194 Women, N=1289
Age categories (years) Prevalence (95%-CI) Calcification volume (IQR) Prevalence (95%-CI) Calcification volume (IQR)
< 65 13.8 (10.1–17.5) 12.3 (2.6–30.3) 10.3 (7.3–13.4) 3.8 (0.8–10.7)
65-75 23.9 (20.5–27.3) 9.0 (2.7–28.7) 16.7 (13.8–19.7) 4.0 (1.3–17.6)
75-85 34.1 (27.9–40.2) 9.6 (2.5–27.2) 31.3 (25.5–37.1) 8.2 (2.2–26.0)
≥85 51.9 (31.7–72.0) 27.2 (3.5–46.4) 48.6 (31.2–66.0) 5.4 (1.9–25.3)
Values represent prevalences in percentages (95%-confidence intervals), and median calcification volumes in mm3 (interquartile range).
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genetic differences [11,35], or vessel-specific anatomical differences in
terms of shapes, curves (turbulent flow) or diameter [36].
With regard to the association of cardiovascular risk factors with the
presence and amount of VBAC, we found hypertension, diabetes, and
current smoking to be most prominently related to VBAC in both sexes.
Thus far, population-based research on associations between cardio-
vascular risk factors with calcification has been restricted to arteries
other than the vertebrobasilar arteries [3,10,13,37–40]. In line with our
results, diabetes, hypertension, and smoking have been identified as
important risk factors for calcification in the coronary arteries, aortic
arch, extracranial- and intracranial carotid arteries [3,10,13,37,39]. In
addition, particularly within the Rotterdam Study, these have been
identified as risk factors for arterial calcification, although the strengths
of associations differed across different vessels and between women and
men [3,13]. Within this population, it has been shown previously that
smoking was an important risk factor for ICAC, AAC, and ECAC with
stronger associations in men than women, whereas diabetes seems to be
a strong risk factor for ECAC, AAC, and ICAC in women, but only for
CAC in men. Hypertension has been identified as strong risk factor for
ICAC and CAC in women, and for AAC in men [3,13]. In contrast with
previous studies that focused on other vessel beds [3,10,13,37–40], we
found no association of low HDL cholesterol with VBAC. Although this
might be due to a small percentage of participants that had a low HDL-
cholesterol, we also found no association between hypercholester-
olemia and VBAC, suggesting that the lipid-metabolism might be less
prominent for the development of VBAC. Interestingly, within the same
population as the current study, it has been shown that hypercholes-
terolemia is one of the strongest risk factors for calcification in the
intracranial carotid artery [3]. Arguably, this difference could relate to
distinct differences between the anatomy of the vertebrobasilar arteries
and the intracranial internal carotid artery. This particular curvature of
the intracranial internal carotid artery (siphon) predisposes to turbulent
flow, which is known to be an important risk factor for cholesterol
depositions in the arterial wall [41]. Conversely, the course of the
vertebrobasilar arteries is rather smooth, without any such curves. Yet,
further research into this topic is required.
Overall, our results show similar patterns of cardiovascular risk
factors for VBAC among men and women. Only obesity showed to be a
prominent determinant for VBAC in men, but not in women.
Interestingly, prior studies reported a tendency towards an inverse as-
sociation between obesity and arterial calcification in women
[3,13,40]. A potential responsible mechanism for this might be related
to estrogen production in fat mass, which could lead to, among others,
favorable alterations of plasma lipoproteins and decrease in chemo-
kines involved in monocyte migration [42,43]. However, some caution
should be taken when interpreting this previously reported paradoxical
association, considering that the underlying sex-specific pathways be-
tween obesity and arterial calcification remain poorly understood.
Nevertheless, more research is necessary to better understand the sex-
specific effects of cardiovascular risk factors on different locations of
arteriosclerosis to improve sex-specific risk assessment strategies for
stroke prevention.
Strengths of our study include the large population size and the
population-based setting. However, our study also has some potential
limitations. First, using CT scans to evaluate calcification in the ver-
tebrobasilar arteries it is not possible to visualize non-calcified plaque.
Nonetheless, previous evidence from autopsy studies demonstrate that
calcification adequately reflects the total underlying plaque burden
[44,45]. Yet, further studies on the interrelation of calcification, non-
calcified plaque, and luminal stenosis in vertebrobasilar arteriosclerosis
Fig. 2. Cardiovascular risk factors and the presence of vertebrobasilar calcification among (A) men and (B) women.
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are warranted. Second, our population mainly comprised elderly per-
sons, which may limit the generalizability of the results to a younger
population. A final methodological consideration is that our relatively
healthy population may contribute to a more restricted range of calci-
fication scores, which, in turn, may potentially lead to an under-
estimation of the associations. Despite these limitations, in the pre-
vention and management of stroke, one may have to consider a
potential different etiology for arteriosclerosis depending on the loca-
tion. In this light, it is of crucial importance to investigate the asso-
ciation of VBAC with the clinical development of stroke, in particular
posterior circulation stroke and stroke subtypes (hemorrhagic and is-
chemic).
In conclusion, the findings of our study provide insight into the
presence and risk factors of VBAC in a middle-aged and elderly com-
munity-dwelling population. The overall prevalence is over 20% and
traditional cardiovascular risk factors are associated with VBAC,
showing homogeneous patterns for men and women. Our results sug-
gest a different pathophysiology of VBAC compared to other major
vessel beds. These findings could be considered in future research
concerning the etiology of posterior arteriosclerosis and might be taken
into account while developing risk factor dependent approaches for
cerebrovascular risk reduction.
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